A Bridging Study of FB2001 in Healthy Subjects

NCT05197179 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: FB2001
OTHER: FB2001 placebo

Sponsor

Frontier Biotechnologies Inc.